| abstract |
A pharmaceutical composition comprising pharmaceutically effective amounts of each of the following components: a) at least one CB channel modulator as a first active agent; and b) at least one CB modulator as a second active agent. The invention also relates to the use of such compositions and to methods of preventing, treating, slowing down development, slowing the onset and / or suppressing a number of diseases, including obesity, diabetes mellitus, metabolic syndrome, syndrome X, insulin, familial hyperinsulin hypoglycemia, male pattern baldness, increased reactivity compressive muscles, asthma, neuroprotection, epilepsy, analgesia, cardioprotection, angina pectoris, cardioplegia, arrhythmia, coronary spasm, peripheral vascular disease, spasm of the brain with convulsions, regulation of appetite, neurodegeneration, pain, including neuropathic pain and chronic pain, and impotence in mammals and humans, and the method comprises administering such compositions to subjects in need of such treatment. The invention also relates to methods for producing such compositions. |